Summit Therapeutics (SMMT) Other Operating Expenses (2019 - 2024)
Summit Therapeutics (SMMT) posted Other Operating Expenses of $205000.0 for Q4 2024, up 177.65% on a QoQ basis from -$264000.0 in Q3 2024, and up 14.53% year-over-year from $179000.0 in Q1 2024.
Summit Therapeutics (SMMT) Other Operating Expenses (2019 - 2024) Analysis & Trends
Summit Therapeutics' Other Operating Expenses history runs 6 years deep, the most recent figure standing at $205000.0 for Q4 2024.
- Quarterly Other Operating Expenses rose 14.53% year-over-year to $205000.0 in Q4 2024, while the trailing twelve-month figure through Sep 2025 was $205000.0 (down 28.57% YoY) and the FY2024 annual result came in at $313000.0, down 68.73% from the prior year.
- Other Operating Expenses was $205000.0 for Q4 2024 at Summit Therapeutics, up from -$264000.0 in the prior quarter.
- Across five years, Other Operating Expenses topped out at $6.8 million in Q1 2020 and bottomed at -$264000.0 in Q3 2024.
- A 5-year average of $2.8 million and a median of $3.4 million in 2020 frame the typical range for Other Operating Expenses.
- Peak annual rise in Other Operating Expenses reached 688.89% in 2024, while the deepest fall reached 199.62% in 2024.
- Summit Therapeutics' Other Operating Expenses stood at $4.4 million in 2020, then increased by 5.18% to $4.6 million in 2021, then tumbled by 75.31% to $1.1 million in 2022, then tumbled by 84.2% to $179000.0 in 2023, then climbed by 14.53% to $205000.0 in 2024.
- Business Quant data shows SMMT's Other Operating Expenses at $205000.0 in Q4 2024, -$264000.0 in Q3 2024, and $159000.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Summit Therapeutics | 10.60 Bn | 10.00 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 205,000.00 |
| Sep 30, 2024 | -264,000.00 |
| Jun 30, 2024 | 159,000.00 |
| Mar 31, 2024 | 213,000.00 |
| Dec 31, 2023 | 179,000.00 |
| Sep 30, 2023 | 265,000.00 |
| Jun 30, 2023 | -27,000.00 |
| Mar 31, 2023 | 584,000.00 |
| Dec 31, 2022 | 1.13 Mn |
| Sep 30, 2022 | 5.46 Mn |
| Jun 30, 2022 | 3.01 Mn |
| Mar 31, 2022 | 4.81 Mn |
| Dec 31, 2021 | 4.59 Mn |
| Sep 30, 2021 | 4.81 Mn |
| Jun 30, 2021 | 6.12 Mn |
| Mar 31, 2021 | 5.45 Mn |
| Dec 31, 2020 | 4.36 Mn |
| Sep 30, 2020 | 4.31 Mn |
| Jun 30, 2020 | 3.82 Mn |
| Mar 31, 2020 | 6.82 Mn |